Pfizer Holds Near $26, Dividend Draws Watch as Drug Prices Cloud Outlook
Pfizer closed at $26.21, up 0.15%, with a 6.6% dividend yield drawing investor interest amid pricing pressure and patent-cliff risk; key catalysts ahead are the August 4 earnings update and an August 17 FDA decision on Padcev-Keytruda, as investors weigh income appeal against growth uncertainty.